1.
DEPO MEDROKSI PROGESTERON ASETAT (DMPA) INCREASES BODY MASS INDEX OF ACCEPTORS BUT DECREASES THEIR LIBIDO. Proceedings of the ICASH. 2017;(2):81-85. Accessed April 16, 2026. https://www.inschool.id/publications/index.php/icash/article/view/880